Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; Verge Genomics; collaboration with AdvanCell to advance novel targeted alpha therapies for the treatment of ...

Other companies are looking at lead-212 RLTs, meanwhile, including ARTBIO and POINT Biopharma/AdvanCell, but Orano Med is thought to be in the lead in the category. Sanofi's chief executive Paul ...

AdvanCell, a clinical-stage radiopharmaceutical company specializing in targeted alpha therapies, today announced an expansion to the scope and breadth of its strategic collaboration with Eli ...

The targeted radiopharmaceutical field is undergoing significant expansion, with progressing clinical candidates and growing novel pipelines. Precision radiopharmaceuticals represent a golden ...

A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. We're maintaining the criteria we used for last ...

Johnson Winter Slattery (JWS) and Baker McKenzie have confirmed their roles in the sale of Sydney-based enterprise risk management software company Protecht Group Holdings Pty Ltd on its $445m sale to ...

At close: March 19 at 1:59:39 PM CST Loading Chart for LLY.MX ...

After hours: 25 March at 7:59:32 pm GMT-4 Loading Chart for LLY ...